NASDAQ Composite opens in less than four hours and Arcturus Therapeutics‘s pre-market value is already 6.44% down.
The last session, NASDAQ Composite ended with Arcturus Therapeutics (ARCT) jumping 11.9% to $28.86. NASDAQ Composite jumped 2.32% to $13,429.98, after two successive sessions in a row of gains, on what was an all-around positive trend trading session.
Arcturus Therapeutics’s last close was $25.79, 349.45% below its 52-week high of $129.71.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is a negative 4% for the ongoing quarter and a decline by 28% for the next. The company’s growth estimates for the present quarter and the next is a negative 86.6% and a negative 163.6%, respectively.
Arcturus Therapeutics’s last day, last week, and last month’s current volatility was 2.02%, 5.43%, and 4.12%, respectively.
Arcturus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 10.25% (day), 8.28% (last week), and 7.18% (last month), respectively.
More news about Arcturus Therapeutics (ARCT).